Sharp-PS® (Soy-Free Sunflower Phosphatidylserine)

Evidence Level
Moderate
5 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Sharp-PS® is IFF Health's (formerly Enzymotec's) line of phosphatidylserine (PS) ingredients: Sharp-PS from soy lecithin, Sharp-PS Green from sunflower lecithin, and Sharp-PS GOLD with omega-3 fats attached. Its own published trials are small. A 12 week study of soy Sharp-PS in 30 older adults with memory complaints reported better recall, but it had no placebo group and all authors were current or former company employees. A placebo-controlled trial of Sharp-PS Green in healthy children found no difference on its main or secondary measures. Like other soy and sunflower PS, it carries different fatty acids from the cow brain PS used in the early memory research.

Studied Dose 300 mg/day of soy Sharp-PS (100 mg three times daily) for 12 weeks in one open-label adult study; 100 mg/day of Sharp-PS Green for 12 weeks in children.
Active Compound Phosphatidylserine (PS) from soy lecithin (Sharp-PS) or sunflower lecithin (Sharp-PS Green); Sharp-PS GOLD is PS-DHA.

Benefits

Memory in older adults: one open-label study

In a 12 week study, 30 people aged 50 to 90 with memory complaints took 300 mg a day of soy Sharp-PS and scored better on recall and recognition tests than at the start. There was no placebo group, so practice and expectation effects cannot be ruled out, and all authors were current or former employees of the ingredient maker.

Sharp-PS Green in healthy children

In a placebo-controlled trial run with the ingredient maker, healthy children aged 8 to 12 took 100 mg a day of Sharp-PS Green for 12 weeks and did no better than placebo on the main or secondary measures. One predefined subgroup with lower starting scores improved on a single visuospatial task.

Omega-3 grade (Sharp-PS GOLD, PS-DHA)

PS-DHA attaches omega-3 fats to PS, so effects cannot be credited to PS alone. In a 15 week trial in 157 older adults with memory complaints, the company's PS-DHA product (Vayacog) improved immediate verbal recall more than placebo; wider gains appeared only post hoc. The company funded the trial and three authors were its employees.

Stress hormones: other PS products only

Trials of other PS products disagree: 600 mg a day of soy PS lowered cortisol after cycling in one 10 man study, 400 and 750 mg a day did not in three others, and a different company's PS plus phosphatidic acid complex helped only highly stressed men. None used Sharp-PS.

Soy-free option (Sharp-PS Green only)

Sharp-PS Green is made from sunflower lecithin, which suits people avoiding soy. Standard Sharp-PS is made from soy lecithin, and Sharp-PS GOLD also contains fish, so check which grade a label names.

Mechanism of action

1

Membrane phospholipid integration

Phosphatidylserine is a major anionic phospholipid in neuronal membranes. PS helps maintain membrane structure and the function of membrane proteins. This is the rationale for taking it, not evidence that a supplement changes brain PS.

2

Neurotransmitter release facilitation

PS in the inner leaflet of presynaptic membranes interacts with vesicle fusion machinery and modulates release of acetylcholine, dopamine, norepinephrine, and serotonin. This is a proposed explanation based mainly on animal work; the human Sharp-PS studies did not measure it.

3

HPA-axis modulation

PS has been proposed to blunt the stress hormone (ACTH and cortisol) response. Small human trials of other PS products disagree, and how this would work is not established.

4

Apoptotic signaling

PS on the outer surface of a cell membrane is the 'eat me' signal that lets immune cells clear dying cells. This is membrane biology, not a known effect of taking PS as a supplement.

Clinical trials

1
PS plus Phosphatidic Acid Complex and Stress Hormones (Not Sharp-PS)
PubMed

Randomized, placebo-controlled trial of a different company's soy PS plus phosphatidic acid complex (Lipogen PAS, 400 mg PS plus 400 mg PA daily for 6 weeks), financed by Lipogen and Lonza. It does not test Sharp-PS. (Hellhammer et al. 2014, Lipids Health Dis)

75 healthy men, grouped by chronic stress.

The 400 mg dose normalized the ACTH and cortisol response to a lab stress test only in men with high chronic stress; 200 mg of each had no effect, and felt stress did not change.

2
Phosphatidylserine for Recovery from Downhill Running
PubMed

Randomized trial of 750 mg/day soybean-derived phosphatidylserine for 7 days before and 2 days after eccentric exercise. Outcomes: muscle soreness, damage markers, recovery. Published in Medicine & Science in Sports & Exercise.

8 recreationally active men; crossover design.

750 mg a day of soy PS did not reduce soreness or markers of muscle damage, inflammation or oxidative stress after downhill running. This was not a Sharp-PS trial.

3
Enzymotec PS-Omega-3 (PS-DHA) for Memory in Non-Demented Elderly with Memory Complaints
PubMed

Randomized, double-blind, placebo-controlled trial of phosphatidylserine plus omega-3 fatty acids (Vayacog, Enzymotec) in non-demented elderly with memory complaints over 15 weeks. Outcomes: memory function tests, sub-group analyses by cognitive status. Published in Dementia and Geriatric Cognitive Disorders.

Non-demented elderly with memory complaints; 15-week intervention.

Immediate verbal recall improved more on PS-DHA than on placebo; wider gains appeared only in a post hoc analysis of people with better starting scores, and the authors called the study exploratory. Funded by Enzymotec; three authors were employees.

4
Soy Sharp-PS and Memory in Older Adults (Open-Label)
PubMed

Exploratory single center open-label study with no placebo group; all authors were current or former Enzymotec employees. (Richter et al. 2013, Clin Interv Aging)

30 adults aged 50 to 90 with memory complaints; 300 mg a day for 12 weeks.

Recall, recognition and word-list learning scores rose from baseline, and blood pressure fell. Without a placebo group these gains cannot be credited to Sharp-PS. Two people stopped because of stomach upset judged probably related.

5
Sharp-PS Green and Cognition in Healthy Children
PubMed

Randomized, placebo-controlled trial of sunflower-derived Sharp-PS Green, 100 mg a day in gummies for 12 weeks. Four of the authors were employees of IFF Health, which sells the ingredient. (Friling et al. 2025, Nutrition Journal)

Healthy children aged 8 to 12.

No differences from placebo on the primary or secondary outcomes in the whole group. A predefined subgroup with below-median starting scores improved on one visuospatial memory task, a lead for further research rather than a result. Stress and cortisol were not measured.

Side effects and drug interactions

Common Potential side effects

Side effects were uncommon in PS trials; in the open Sharp-PS study, 2 of 30 people stopped because of stomach upset.
Standard Sharp-PS is made from soy and is not suitable for people with a soy allergy; Sharp-PS Green is the sunflower grade, and Sharp-PS GOLD also contains fish.
Pregnancy and breastfeeding: we found no safety data; ask a health professional before use.

Important Drug interactions

Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine): a theoretical added effect on acetylcholine, not studied. Tell your prescriber.
Anticholinergic medicines: a theoretical opposing effect, not studied.
Blood thinners and antiplatelet drugs: we found no interaction study; tell your prescriber if combining.

Frequently asked questions about Sharp-PS® (Soy-Free Sunflower Phosphatidylserine)

What is Sharp-PS?

Sharp-PS® is IFF Health's (formerly Enzymotec's) line of phosphatidylserine (PS) ingredients: Sharp-PS from soy lecithin, Sharp-PS Green from sunflower lecithin, and Sharp-PS GOLD with omega-3 fats attached. Its own published trials are small.

What is Sharp-PS used for?

Sharp-PS is researched primarily for Cognitive, Stress & Anxiety, and Mood & Mental Health. In a 12 week study, 30 people aged 50 to 90 with memory complaints took 300 mg a day of soy Sharp-PS and scored better on recall and recognition tests than at the start.

What is the recommended dosage of Sharp-PS?

The clinically studied dose is 300 mg/day of soy Sharp-PS (100 mg three times daily) for 12 weeks in one open-label adult study; 100 mg/day of Sharp-PS Green for 12 weeks in children. Always follow the product label and check with a healthcare provider for personal advice.

Is Sharp-PS safe, and does it have side effects?

Side effects and cautions reported for Sharp-PS include: Side effects were uncommon in PS trials; in the open Sharp-PS study, 2 of 30 people stopped because of stomach upset. Standard Sharp-PS is made from soy and is not suitable for people with a soy allergy; Sharp-PS Green is the sunflower grade, and Sharp-PS GOLD also contains fish. It may also interact with some medications. Sharp-PS is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Sharp-PS interact with any medications?

Possible interactions include: Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine): a theoretical added effect on acetylcholine, not studied. Tell your prescriber. Anticholinergic medicines: a theoretical opposing effect, not studied. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Sharp-PS?

NutraSmarts rates the evidence for Sharp-PS as Moderate (3 out of 5). It is backed by 5 study summaries and 5 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(5 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hellhammer J, Vogt D, Franz N, Freitas U, Rutenberg D. A soy-based phosphatidylserine/phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study. Lipids Health Dis. 2014;13:121. doi: 10.1186/1476-511X-13-121.PubMedUsed to support: Trial of a different company's soy PS plus phosphatidic acid complex (Lipogen PAS) in 75 men: 400 mg of each daily for 42 days normalized ACTH and cortisol responses to a lab stress test only in highly stressed men; financed by Lipogen and Lonza. Not a Sharp-PS trial.
  2. Kingsley MI, Kilduff LP, McEneny J, Dietzig RE, Benton D. Phosphatidylserine supplementation and recovery following downhill running. Med Sci Sports Exerc. 2006;38(9):1617-25. doi: 10.1249/01.mss.0000229459.11452.a0.PubMedUsed to support: Double blind crossover trial in 8 recreationally active men: 750 mg a day of soy PS for 7 days before and 2 days after downhill running did not reduce soreness or markers of muscle damage, inflammation or oxidative stress. Not a Sharp-PS trial.
  3. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467-74. doi: 10.1159/000310330.PubMedUsed to support: RCT in non-demented elderly with memory complaints — PS containing omega-3 fatty acids (Enzymotec's PS-DHA, Vayacog) improved immediate verbal recall more than placebo; wider gains appeared only post hoc; Enzymotec-funded, over 15 weeks.
  4. Richter Y, Herzog Y, Lifshitz Y, Hayun R, Zchut S. The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. Clin Interv Aging. 2013;8:557-63. doi: 10.2147/CIA.S40348.PubMedUsed to support: Open-label pilot study with no placebo group in 30 adults aged 50 to 90 with memory complaints: 300 mg a day of soy PS (Sharp-PS) for 12 weeks was followed by better memory recognition, recall and learning scores than at the start, and lower blood pressure. All authors were current or former Enzymotec employees.
  5. Friling M, Jackson PA, Kennedy D, Dodd F, Smith E, Lavie A, Lopresti A, Ivanir E, Jalanka J. The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial. Nutr J. 2025;25(1):3. doi: 10.1186/s12937-025-01264-9.PubMedUsed to support: Randomized, placebo-controlled trial in healthy children aged 8 to 12: 100 mg a day of sunflower PS (Sharp-PS Green) in gummies for 12 weeks found no differences from placebo in primary or secondary outcomes; a predefined below-median subgroup improved on one visuospatial memory task. Four authors were IFF Health employees.